Neurofilament (PT0124R) rabbit mAb
- Catalog No.:YM7175
- Applications:IHC;WB; ELISA
- Reactivity:Human;
- Target:
- NF-L
- Fields:
- >>Amyotrophic lateral sclerosis;>>Pathways of neurodegeneration - multiple diseases
- Gene Name:
- NEFL
- Protein Name:
- Neurofilament
- Human Gene Id:
- 4747
- Human Swiss Prot No:
- P07196
- Immunogen:
- Synthesized peptide derived from human Neurofilament AA range:400-543
- Specificity:
- This antibody detects endogenous levels of NF-L
- Formulation:
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Source:
- Monoclonal, Rabbit IgG1, Kappa
- Dilution:
- IHC 1:100-500, WB 1:500-1000, ELISA 1:5000-20000
- Purification:
- Recombinant Expression and Affinity purified
- Storage Stability:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Other Name:
- 150 kDa medium;160 kDa neurofilament protein;2 kDa neurofilament protein;200 kDa neurofilament protein;68 kDa neurofilament protein;AI847934;CMT1F;CMT2CC;CMT2E;FLJ53642;KIAA0845;light molecular weight neurofilament protein;Micro glutamic acid-rich protein;mKIAA0845;Nef3;NEFH;NEFL;NEFM;Neurofilament 3;Neurofilament heavy polypeptide 200 kDa;Neurofilament heavy polypeptide;Neurofilament light polypeptide 68 kDa;Neurofilament light polypeptide;Neurofilament medium polypeptide 150 kDa;Neurofilament medium polypeptide;Neurofilament protein heavy polypeptide;Neurofilament protein light chain;Neurofilament protein light polypeptide;Neurofilament protein medium polypeptide;neurofilament subunit NF-L;Neurofilament triplet H protein;Neurofilament triplet L protein;Neurofilament triplet M protein;neurofilament-3 (150 kD medium);NF-H;NF-L;NF-M;NF160;NF165;NF200;NF68;NFH;NFL;NFM;NFM_HUMAN;PPP1R110;protein phosphatase 1, regulatory subunit 110
- Molecular Weight(Da):
- 62kD
- Background:
- Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and they functionally maintain the neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the light chain neurofilament protein. Mutations in this gene cause Charcot-Marie-Tooth disease types 1F (CMT1F) and 2E (CMT2E), disorders of the peripheral nervous system that are characterized by distinct neuropathies. A pseudogene has been identified on chromosome Y. [provided by RefSeq, Oct 2008],
- Function:
- caution:The sequence shown here is derived from an Ensembl automatic analysis pipeline and should be considered as preliminary data.,disease:Defects in NEFL are the cause of Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734]. CMT1F is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy or CMT1, and primary peripheral axonal neuropathy or CMT2. Neuropathies of the CMT1 group are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. CMT1F is charac
- Subcellular Location:
- Cytoplasmic
- Expression:
- Cytoplasmic
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs